142 related articles for article (PubMed ID: 8891736)
1. High frequency of altered HLA class I phenotypes in invasive breast carcinomas.
Cabrera T; Angustias Fernandez M; Sierra A; Garrido A; Herruzo A; Escobedo A; Fabra A; Garrido F
Hum Immunol; 1996 Oct; 50(2):127-34. PubMed ID: 8891736
[TBL] [Abstract][Full Text] [Related]
2. High frequency of altered HLA class I phenotypes in invasive colorectal carcinomas.
Cabrera T; Collado A; Fernandez MA; Ferron A; Sancho J; Ruiz-Cabello F; Garrido F
Tissue Antigens; 1998 Aug; 52(2):114-23. PubMed ID: 9756399
[TBL] [Abstract][Full Text] [Related]
3. Investigation of HLA class I downregulation in breast cancer by RT-PCR.
Palmisano GL; Pistillo MP; Capanni P; Pera C; Nicolò G; Salvi S; Perdelli L; Pasciucco G; Ferrara GB
Hum Immunol; 2001 Feb; 62(2):133-9. PubMed ID: 11182222
[TBL] [Abstract][Full Text] [Related]
4. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
Kageshita T; Ishihara T; Campoli M; Ferrone S
Tissue Antigens; 2005 May; 65(5):419-28. PubMed ID: 15853896
[TBL] [Abstract][Full Text] [Related]
5. High frequency of altered HLA class I phenotypes in laryngeal carcinomas.
Cabrera T; Salinero J; Fernandez MA; Garrido A; Esquivias J; Garrido F
Hum Immunol; 2000 May; 61(5):499-506. PubMed ID: 10773352
[TBL] [Abstract][Full Text] [Related]
6. Multiple mechanisms generate HLA class I altered phenotypes in laryngeal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21.
Maleno I; López-Nevot MA; Cabrera T; Salinero J; Garrido F
Cancer Immunol Immunother; 2002 Sep; 51(7):389-96. PubMed ID: 12192539
[TBL] [Abstract][Full Text] [Related]
7. Histocompatibility antigens in primary and metastatic squamous cell carcinoma of the larynx.
Esteban F; Concha A; Huelin C; Pérez-Ayala M; Pedrinaci S; Ruiz-Cabello F; Garrido F
Int J Cancer; 1989 Mar; 43(3):436-42. PubMed ID: 2647639
[TBL] [Abstract][Full Text] [Related]
8. High frequency of HLA-B44 allelic losses in human solid tumors.
Cabrera T; Maleno I; Lopez-Nevot MA; Redondo M; Fernandez MA; Collado A; Garrido F
Hum Immunol; 2003 Oct; 64(10):941-50. PubMed ID: 14522091
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies as a tool for phylogenetic studies of major histocompatibility antigens and beta 2-microglobulin.
Teillaud JL; Crevat D; Chardon P; Kalil J; Goujet-Zalc C; Mahouy G; Vaiman M; Fellous M; Pious D
Immunogenetics; 1982; 15(4):377-84. PubMed ID: 6176537
[TBL] [Abstract][Full Text] [Related]
10. HLA-E-restricted recognition of human cytomegalovirus by a subset of cytolytic T lymphocytes.
Romagnani C; Pietra G; Falco M; Mazzarino P; Moretta L; Mingari MC
Hum Immunol; 2004 May; 65(5):437-45. PubMed ID: 15172443
[TBL] [Abstract][Full Text] [Related]
11. HLA class I expression in bladder carcinomas.
Cabrera T; Pedrajas G; Cozar JM; Garrido A; Vicente J; Tallada M; Garrido F
Tissue Antigens; 2003 Oct; 62(4):324-7. PubMed ID: 12974799
[TBL] [Abstract][Full Text] [Related]
12. LOH at 6p21.3 region and HLA class I altered phenotypes in bladder carcinomas.
Maleno I; Romero JM; Cabrera T; Paco L; Aptsiauri N; Cozar JM; Tallada M; López-Nevot MA; Garrido F
Immunogenetics; 2006 Jul; 58(7):503-10. PubMed ID: 16705407
[TBL] [Abstract][Full Text] [Related]
13. Effect of monoclonal antibodies (MoAb) to class I and class II HLA antigens on lectin- and MoAb OKT3-induced lymphocyte proliferation.
Akiyama Y; Zicht R; Ferrone S; Bonnard GD; Herberman RB
Cell Immunol; 1985 Apr; 91(2):477-91. PubMed ID: 2581701
[TBL] [Abstract][Full Text] [Related]
14. Selective loss of HLA-A or HLA-B antigen expression in colon carcinoma.
Momburg F; Ziegler A; Harpprecht J; Möller P; Moldenhauer G; Hämmerling GJ
J Immunol; 1989 Jan; 142(1):352-8. PubMed ID: 2462591
[TBL] [Abstract][Full Text] [Related]
15. HLA-E monoclonal antibodies recognize shared peptide sequences on classical HLA class Ia: relevance to human natural HLA antibodies.
Ravindranath MH; Taniguchi M; Chen CW; Ozawa M; Kaneku H; El-Awar N; Cai J; Terasaki PI
Mol Immunol; 2010 Feb; 47(5):1121-31. PubMed ID: 19944464
[TBL] [Abstract][Full Text] [Related]
16. Molecular localization and polymorphism of HLA class II restriction determinants defined by Mycobacterium leprae-reactive helper T cell clones from leprosy patients.
Ottenhoff TH; Neuteboom S; Elferink DG; de Vries RR
J Exp Med; 1986 Dec; 164(6):1923-39. PubMed ID: 2431092
[TBL] [Abstract][Full Text] [Related]
17. Loss of monomorphic and polymorphic HLA antigens in metastatic breast and colon carcinoma.
Goepel JR; Rees RC; Rogers K; Stoddard CJ; Thomas WE; Shepherd L
Br J Cancer; 1991 Nov; 64(5):880-3. PubMed ID: 1718386
[TBL] [Abstract][Full Text] [Related]
18. Expression of cell surface antigens during allogeneic response studies with monoclonal antibodies to a polymorphic marker of activated lymphocytes and HLA class I and class II antigens.
Wollman EE; Kalil J
Tissue Antigens; 1983 Jul; 22(1):37-41. PubMed ID: 6225221
[TBL] [Abstract][Full Text] [Related]
19. Differential regulatory role of monomorphic and polymorphic determinants of histocompatibility leukocyte antigen class I antigens in monoclonal antibody OKT3-induced T cell proliferation.
De Felice M; Turco MC; Giarrusso PC; Corbo L; Pizzano R; Martinelli V; Ferrone S; Venuta S
J Immunol; 1987 Oct; 139(8):2683-9. PubMed ID: 2443568
[TBL] [Abstract][Full Text] [Related]
20. Analysis of HLA-E expression in human tumors.
Marín R; Ruiz-Cabello F; Pedrinaci S; Méndez R; Jiménez P; Geraghty DE; Garrido F
Immunogenetics; 2003 Feb; 54(11):767-75. PubMed ID: 12618909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
